Curriculum Vitae of Dennis Leveson-Gower, Ph.D.


MANUSCRIPTS (click title for PDF)


Leveson-Gower, DB, Sega EI, Kalesnikoff J, Florek M, Galli S, Negrin RS. Mast cells suppress GVHD in a mechanism involving IL-10 production, but independent of CD4+CD25+ regulatory T cells.  In Submission.


Shin HJ, Baker J, Leveson-Gower, DB, Smith A, Sega EI, Negrin RS. Rapamycin and IL-2 reduces lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood. 2011 Aug 25; 118(8): 2342-50. 2011.


Leveson-Gower DB, Olson JA, Sega EI, Luong RH, Baker J, Zeiser R, Negrin RS. Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4 dependent mechanism.  Blood. 2011 Mar 17; 117(11):3320-9.


Pearl JI, Lee A, Leveson-Gower, DB, Sun N, Ghosh Z, Lan F, Ransohoff J, Negrin RS, Davis MM, Wu JC.  Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell. 2011 Mar 4;8(3):309-17.


Olson JA, Leveson-Gower, DB, Gill S, Baker J, Beilhack A, Negrin RS. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood. 2010 May 27;115(21):4293-301.


Zeiser R, Leveson-Gower, DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS.  Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood. 2008 Jan 1;111(1):453-62.


Zeiser R, Zambricki E, Leveson-Gower, DB, Beilhack A, Negrin RS.  Host derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease.  Biology of Blood and Marrow Transplantation. 2007 Dec; 13(12):1427-38


Leveson-Gower, DB, Michnick SW, Ling V.  Detection of TAP Family Dimerizations by an In Vivo Assay in Mammalian Cells. Biochemistry. 2004 Nov 9; 43(44):14257-64.